Predictive Oncology Inc. financial data

Symbol
POAI on Nasdaq
Location
Pittsburgh, PA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 8.78 % -94.7%
Quick Ratio 0.19 % -98%
Debt-to-equity -122 % -191%
Return On Equity 425 %
Return On Assets -1.94K % -1485%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 3.39M shares -49.1%
Common Stock, Shares, Outstanding 767K shares -88.5%
Entity Public Float 5.82M USD -69.3%
Common Stock, Value, Issued 7.67K USD -88.5%
Weighted Average Number of Shares Outstanding, Basic 724K shares +69.8%
Weighted Average Number of Shares Outstanding, Diluted 724K shares +69.8%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 98.1K USD -69.4%
Selling and Marketing Expense 424K USD -47.3%
General and Administrative Expense 7.86M USD +27.3%
Operating Income (Loss) -10.3M USD -12.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -84.3M USD -540%
Earnings Per Share, Basic -101 USD/shares -928%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 182K USD -94.1%
Accounts Receivable, after Allowance for Credit Loss, Current 26K USD -94.4%
Inventory, Net 38K USD -92.5%
Assets, Current 1.1M USD -75.8%
Property, Plant and Equipment, Net 253K USD -37.2%
Operating Lease, Right-of-Use Asset 1.63M USD -25.9%
Intangible Assets, Net (Excluding Goodwill) 47.5K USD -78.5%
Other Assets, Noncurrent 98.5K USD -3.93%
Assets 3.14M USD -58.2%
Accounts Payable, Current 2.72M USD +138%
Accrued Liabilities, Current 1.13M USD -25.3%
Contract with Customer, Liability, Current 147K USD -43.1%
Liabilities, Current 79.5M USD +1983%
Operating Lease, Liability, Noncurrent 1.08M USD -36.8%
Other Liabilities, Noncurrent 23.5K USD +330%
Liabilities 80.6M USD +1357%
Retained Earnings (Accumulated Deficit) -263M USD -47.3%
Stockholders' Equity Attributable to Parent -77.4M USD -4036%
Liabilities and Equity 3.14M USD -58.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.42M USD +0.34%
Net Cash Provided by (Used in) Financing Activities -112K USD
Net Cash Provided by (Used in) Investing Activities -3.03K USD +93.5%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 767K shares
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.37M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 182K USD -93.9%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.8K USD +3.45%
Deferred Tax Assets, Valuation Allowance 27.1M USD +10.3%
Deferred Tax Assets, Gross 27.6M USD +9.41%
Operating Lease, Liability 1.7M USD -22.6%
Depreciation 126K USD +0.85%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 1.97M USD -27.3%
Property, Plant and Equipment, Gross 2.03M USD -22.8%
Operating Lease, Liability, Current 628K USD +26.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 828K USD +3.01%
Lessee, Operating Lease, Liability, to be Paid, Year One 804K USD +0.68%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 262K USD -48.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 139K USD -83.2%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 139K USD -83.2%
Additional Paid in Capital 185M USD +2.78%
Amortization of Intangible Assets 4.68K USD -8.19%
Depreciation, Depletion and Amortization 32.6K USD -3.94%
Share-based Payment Arrangement, Expense 405K USD